Terms: = Uterine cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Diagnosis
8 results:
1. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
2. Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.
Ngune I; Kalembo F; Loessl B; Kivuti-Bitok LW
PLoS One; 2020; 15(8):e0237745. PubMed ID: 32817627
[TBL] [Abstract] [Full Text] [Related]
3. Expression of immune cell markers and tumor markers in patients with cervical cancer.
Zhang L; Zhang H; Huang Y; Xi X; Sun Y
Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
[TBL] [Abstract] [Full Text] [Related]
4. Invasive cervical cancer after treatment of CIN.
Herbert A; Culora G; McLean E; Kubba AA;
J Am Soc Cytopathol; 2019; 8(6):324-332. PubMed ID: 31523013
[TBL] [Abstract] [Full Text] [Related]
5. Black and white women in Maryland receive different treatment for cervical cancer.
Fleming S; Schluterman NH; Tracy JK; Temkin SM
PLoS One; 2014; 9(8):e104344. PubMed ID: 25121587
[TBL] [Abstract] [Full Text] [Related]
6. Cervical cancer screening in the US-Mexico border region: a binational analysis.
Herrera DG; Schiefelbein EL; Smith R; Rojas R; Mirchandani GG; McDonald JA
Matern Child Health J; 2012 Dec; 16 Suppl 2(0 2):298-306. PubMed ID: 22965734
[TBL] [Abstract] [Full Text] [Related]
7. Longitudinal trends in cervical cytological lesions and the effect of risk factors. A 30-year overview.
Sigurdsson K; Sigvaldason H
Acta Obstet Gynecol Scand; 2006; 85(3):350-8. PubMed ID: 16553185
[TBL] [Abstract] [Full Text] [Related]
8. Central nervous system involvement in gestational trophoblastic neoplasia.
Ayhan A; Tuncer ZS; Tanir M; Erbengi A
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):548-50. PubMed ID: 8693931
[TBL] [Abstract] [Full Text] [Related]